DDVIX
Price
$14.14
Change
+$0.06 (+0.43%)
Updated
Jul 3 closing price
Net Assets
2.24B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DDVIX vs VVIAX

Header iconDDVIX vs VVIAX Comparison
Open Charts DDVIX vs VVIAXBanner chart's image
Macquarie Value Inst
Price$14.14
Change+$0.06 (+0.43%)
VolumeN/A
Net Assets2.24B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DDVIX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDVIX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDVIX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. DDVIX (2.25B). VVIAX pays higher dividends than DDVIX: VVIAX (2.18) vs DDVIX (1.61). DDVIX was incepted earlier than VVIAX: DDVIX (27 years) vs VVIAX (25 years). DDVIX (0.72) is less costly to investors than VVIAX (0.05). DDVIX is a more actively managed with annual turnover of: 31.00 vs. VVIAX (9.00). DDVIX has a lower initial minimum investment than VVIAX: DDVIX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. DDVIX (-15.78). VVIAX return over 5 years is better than : 80.13 vs. DDVIX (-19.99).
DDVIXVVIAXDDVIX / VVIAX
Total Expense Ratio0.720.051,440%
Annual Report Gross Expense Ratio0.720.051,440%
Fund Existence27 years25 years-
Gain YTD4.5296.19873%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B189B1%
Annual Yield % from dividends1.612.1874%
Returns for 1 year-15.7812.03-131%
Returns for 3 years-22.7935.17-65%
Returns for 5 years-19.9980.13-25%
Returns for 10 years-12.22115.67-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.